Alzheimer Europe will be contributing to a project of the European Academy of Neurology (EAN), on the burden of sleep-wake disorders and has signed a memorandum of understanding on this collaboration. Other partners in the project include: European Federation of Neurological Associations, European Psychiatric Association, European Paediatric Neurology Society, European Sleep Research Society, plus an independent expert on pulmonology / Scientific Communication. This new EAN study, on the topic of sleep-wake disorders, was initially inspired by the European Brain Council's "Value of Treatment" projects. This research intends not only to systematically assess the scientific literature on this topic but also to explore the socio-economic consequences of insomnia and daytime sleepiness, taking into consideration a patient-centred perspective.
Sleep-wake disorders are prevalent phenomena that significantly affect individuals´ health, their social relationships, educational and professional performance, and quality of life. Although common in the general population, they tend to be regularly underdiagnosed; treatment is frequently not evidence-based; self-treatment is an issue. Moreover, sleep-wake disorders might constitute the first signs of a latent brain disorder. Iva Holmerová, Chairperson, will represent Alzheimer Europe in project meetings and discussions. You can find out more about the project and its objectives, here: https://www.ean.org/research/projects/sleep-wake-disorders
